open access

Vol 52, No 4 (2021)
Editorial
Submitted: 2021-08-03
Accepted: 2021-08-03
Get Citation

Scientific life is changing: virtual and real-world experience

Jan Styczyński1
DOI: 10.5603/AHP.2021.0042
·
Acta Haematol Pol 2021;52(4):215-216.
Affiliations
  1. Department of Paediatric Haematology and Oncology, Jurasz University Hospital, Collegium Medicum, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland

open access

Vol 52, No 4 (2021)
EDITORIAL
Submitted: 2021-08-03
Accepted: 2021-08-03

Abstract

Not available

Abstract

Not available
Get Citation

Keywords

hematology, hemato-oncology

About this article
Title

Scientific life is changing: virtual and real-world experience

Journal

Acta Haematologica Polonica

Issue

Vol 52, No 4 (2021)

Article type

Editorial

Pages

215-216

DOI

10.5603/AHP.2021.0042

Bibliographic record

Acta Haematol Pol 2021;52(4):215-216.

Keywords

hematology
hemato-oncology

Authors

Jan Styczyński

References (10)
  1. Czyżewski K, Sedláček P, Štěrba J, et al. Progress and trends in pediatric hematopoietic cell transplantation in Central-East European countries. Acta Haematol Pol. 2020; 51(3): 142–150.
  2. Styczynski J, Tridello G, Gil L, et al. Prognostic impact of Epstein-Barr virus serostatus in patients with nonmalignant hematological disorders undergoing allogeneic hematopoietic cell transplantation: the study of Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation. Acta Haematol Pol. 2020; 51(2): 73–80.
  3. Jędrzejczak WW. Polish hematology: from here to the future. Acta Haematol Pol. 2021; 52(1): 2–3.
  4. Giebel S, Basak G, Bieniaszewska M, et al. Current status and progress of Polish hemato-oncology. Acta Haematol Pol. 2021; 52(1): 4–17.
  5. Snowden JA, Styczyński J, Snarski E, et al. Haematopoietic stem cell transplantation in autoimmune diseases; an update from the EBMT Autoimmune Diseases Working Party with special reference to Poland. Acta Haematol Pol. 2021; 52(4): 217–224.
  6. Undas A. Anticoagulant treatment of venous thromboembolism in pregnant women. Acta Haematol Pol. 2021; 52(4): 413–418.
  7. Grześk G. Therapeutic monitoring of direct oral anticoagulants — a 8-year observational study. Acta Haematol Pol. 2021; 52(4): 443–449.
  8. Musiał J. Risk assessment of recurrent venous thromboembolism. Acta Haematol Pol. 2021; 52(4): 433–438.
  9. Bembnista E. Implementation of CAR-T technology into clinical practice: challenge for cell bank. Acta Haematol Pol. 2021; 52(4): 263–267.
  10. Firczuk M. Old and new targets for immunotherapy of B cell acute lymphoblastic leukemia. Acta Haematol Pol. 2021; 52(4): 291–299.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl